Table 3

ABIM-CE performance by year group and elective exposure
2006 (n=25) 2007 (n=27) 2008 (n=21) 2009 (n=31) 2010 (n=27) TOTAL
n Mean delta-SPS (95% CI) n Mean delta-SPS (95% CI) n Mean delta-SPS (95% CI) n Mean delta-SPS (95% CI) n Mean delta-SPS (95% CI) n Mean delta-SPS (95% CI)
Cardiology Exposed 19 158.9 21 172.3 17 122.5 31 112.7 25 92.6 113 128.6
(123.4 - 194.5) (137.4-207.3) (80.0-165.1) (82.7-142.8) (56.4-128.9) (112.7-144.5)
Unexposed 6 172.8 6 165.5 4 188.3 0 - 2 139.5 18 170.1
(111.5-234.2) (90.2-240.8) (39.4-337.1) (69.6-209.4) (137.6-202.6)
p 0.68 0.85 0.18 - 0.47 0.05
Endocrinology Exposed 17 149.0 15 192.7 14 141.1 19 104.8 23 104.7 88 134.1
(108.7-189.3) (145.8-239.5) (81.8-200.5) (64.6-145.0) (67.9-141.6) (114.9-153.3)
Unexposed 8 190.5 12 143.5 7 122.9 12 125.3 4 46.5 43 134.8
(161.8-219.2) (111.7-175.3) (83.7-162.0) (73.5-177.0) (−78.1-171.0) (113.7-155.8)
p 0.17 0.09 0.66 0.51 0.21 0.96
Gastroenterology Exposed 9 143.7 16 168.6 12 152.2 22 109.3 23 105.6 82 129.9
(95.5-191.9) (130.4-206.8) (85.4-218.9) (75.3-143.4) (67.7-143.4) (111.3-148.4)
Unexposed 16 172.8 11 174.1 9 112.2 9 121.0 4 41.8 49 141.7
(133.9-211.6) (119.3-228.9) (73.7-150.7) (45.8-196.2) (−33.7-117.2) (118.0-165.5)
p 0.33 0.85 0.31 0.73 0.17 0.43
Hematology Exposed 4 136.3 14 167.4 12 139.3 15 115.5 20 111.6 65 131.1
(44.9-227.6) (122.3-212.5) (93.1-185.4) (71.6-159.5) (70.7-152.4) (111.3-151.0)
Unexposed 21 167.2 13 174.5 9 129.4 16 110.1 7 52.0 66 137.4
(134.6-199.9) (130.2-218.7) (47.4-211.5) (63.9-156.3) (−8.9-112.9) (115.9-158.9)
p 0.43 0.81 0.8 0.86 0.11 0.67
Infectious Diseases Exposed 24 162.2 24 167.0 16 135.7 24 111.5 23 94.9 111 134.5
(132.2-192.2) (135.5-198.5) (101.0-170.4) (76.0-147.0) (61.3-128.5) (119.6-149.5)
Unexposed 1 164.0 3 201.0 5 133.0 7 116.9 4 103.3 20 133.2
(2.1-399.9) (−49.0-315.0) (142.4-191.3) (−114.7-321.2) (83.5-182.8)
p - 0.47 0.95 0.88 0.36 0.95
Oncology Exposed 8 150.9 13 167.4 12 139.3 15 115.5 20 111.6 69 133.1
(92.0-209.7) (122.3-212.5) (93.1-185.4) (71.6-159.5) (70.7-152.4) (113.8-152.4)
Unexposed 17 167.6 14 174.5 9 129.4 16 110.1 7 52.0 62 135.6
(131.5-204.0) (130.2-218.7) (47.4-211.5) (63.9-156.3) (−8.9-112.9) (113.3-157.9)
p 0.58 0.81 0.80 0.86 0.11 0.87
Nephrology Exposed 17 161.9 16 172.4 14 169.6 17 119.2 13 62.9 77 129.9
(135.1-188.6) (134.4-210.5) (101.4-237.7) (76.2-162.2) (22.3-103.5) (111.5-148.3)
Unexposed 8 163.1 11 168.5 7 117.8 14 104.9 14 126.9 54 140.6
(77.8-248.4) (113.3-223.6) (66.0-169.6) (57.4-152.3) (74.4-179.5) (116.6-164.5)
p 0.97 0.89 0.20 0.63 0.049 0.48
Pulmonary Exposed 19 164.4 19 181.5 15 158.3 21 117.1 19 99.8 93 143.0
(127.1-201.8) (144.4-218.5) (113.5-203.2) (53.8-145.8) (125.1-160.9) (76.5-81.1)
Unexposed 6 155.5 8 145.5 6 76.8 10 103.5 8 87.4 38 112.9
(114.1-196.9) (90.5-200.5) (−3.6-157.3) (37.7-137.1) (89.4-136.5) (69.8-76.7)
p 0.79 0.26 0.048 0.67 0.74 0.06
Rheumatology Exposed 18 150.0 19 176.9 12 171.9 22 126.3 18 94.1 89 141.5
(120.8-179.2) (138.3-215.6) (119.3-224.6) (92.8-159.8) (52.1-136) (124.5-158.5)
Unexposed 7 193.9 8 156.3 9 85.9 9 79.4 9 100.2 42 119.0
(111.3-276.4) (105.7-206.8) (34.3-137.5) (8.8-150.1) (29.3-171.1) (91.3-146.6)
p 0.16 0.52 0.0197 0.15 0.86 0.15
Primary Care Exposed 6 212.3 7 168.7 5 146.4 5 108.2 7 99.7 30 144.3
(137.2-287.5) (103.2-234.2) (18.4-274.4) (25.9-190.5) (19.8-151.9) (112.6-176.0)
Unexposed 19 146.5 20 171.6 16 131.5 26 113.6 20 85.9 101 131.3
(116.3-176.7) (135.3-207.8) (86.6-176.4) (79.0-148.2) (57.0-142.4) (114.9-147.8)
p 0.04 0.93 0.74 0.89 0.72 0.50

Scores are reported as difference in standardized score compared to standardized passing score (delta-SPS) reported as mean (95% confidence interval). p-values represent comparison of exposed to unexposed residents for each elective exposure analyzed using unpaired two tailed t-test.

Shanmugam et al.

Shanmugam et al. BMC Medical Education 2012 12:94   doi:10.1186/1472-6920-12-94

Open Data